Cardiovascular disease (CVD) remains the leading global cause of death, affecting millions of lives each year. Despite the urgent need for innovative therapies, the pace of cardiovascular drug development has slowed in recent decades, leaving significant unmet medical needs. At Insignia Clinical Services, we are dedicated to accelerating the development of groundbreaking cardiovascular treatments by offering comprehensive clinical trial management, regulatory expertise, and patient-centric solutions. Our mission is to empower pharmaceutical and biotech companies to bring safer, more effective therapies to market-faster and with greater confidence.